Zantac and Ranitidine
The FDA has issued a warning for people taking the widely-known heartburn medication Zantac and its generic version ranitidine. Preliminary tests found that they contain NDMA, a suspected carcinogen.
FDA is alerting the public that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain low levels of a probable human carcinogen. The FDA is currently evaluating whether there is risk to patients. https://t.co/feHOoyfm8C pic.twitter.com/ut5bFG9JeB
— U.S. FDA (@US_FDA) September 13, 2019
Valisure, an online pharmacy, tested both Zantac the generic version and found out both of them had higher levels of NDMA than recommended by the FDA. The FDA then retested and found lower, but still dangerous, levels of the potentially cancer-causing substance.
NDMA was also found in certain blood pressure medications, which also prompted recalls.
Valisure has requested that the FDA issued a recall of Zantac and its generic versions. An official recall has not yet been announced and the FDA does not recommend people stop taking their medication. If you wish to discontinue any prescription, always consult your doctor first.
Plastikon Healthcare Brand Milk of Magnesia
Milk of magnesia is commonly used to relieve constipation and reduce stomach acid. However, if you have the Plastikon Healthcare brand on your shelf, then you may want to stop taking it. The company has issued a voluntary recall of their 2400mg strength milk of magnesia due to microbial contamination.
Plastikon Healthcare Issues Voluntary Nationwide Recall of Milk of Magnesia Oral Suspension 2400 mg/30 mL due to Microbial Contamination https://t.co/Ke5cjEjP7G pic.twitter.com/lNzVsyccN5
— U.S. FDA (@FDArecalls) September 10, 2019
The affected lots are 19027E and 19027S. Microbial contamination is especially dangerous for patients who are immunocompromised and have a higher chance of developing an infection. Luckily, no infections caused by the contamination have been reported so far.
KRS Global Biotechnology
KRS Global Biotechnology, a drug compounding facility, is issuing a voluntary recall of all of its unexpired human and animal drugs. The company reported that the products may have gone through a faulty sterilization process.
KRS Global Biotechnology, Inc. Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products Due to Lack of Assurance of Sterility https://t.co/VB47FmE6y6 pic.twitter.com/8LuIf8usbh
— U.S. FDA (@FDArecalls) September 13, 2019
Using non-sterile drugs is very risky and can cause life-threatening infections. The recalled drugs produced by KRS Global Biotechnology were sent to hospitals, doctor’s offices, pharmacies, patients and vet clinics.
KRS has been notifying customers by mail, telephone, and email. Credit will be issued to customers for all recalled products. The FDA recommends that all customers stop using medication from KRS and to contact a doctor or other health care provider.
Consumers with questions regarding this recall can contact KRS Global Biotechnology, Inc. by phone 888-398-9950 or email at [email protected].
Copyright 2019, UnitedVoice.com
